Cargando…

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy

INTRODUCTION: A titration within a certain therapeutic reference range presupposes a relationship between the blood concentration and the therapeutic effect of a drug. However, this has not been systematically investigated for escitalopram. Furthermore, the recommended reference range disagrees with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichentopf, Luzie, Hiemke, Christoph, Conca, Andreas, Engelmann, Jan, Gerlach, Manfred, Havemann-Reinecke, Ursula, Hefner, Gudrun, Florio, Vincenzo, Kuzin, Maxim, Lieb, Klaus, Reis, Margareta, Riemer, Thomas G., Serretti, Alessandro, Schoretsanitis, Georgios, Zernig, Gerald, Gründer, Gerhard, Hart, Xenia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621321/ https://www.ncbi.nlm.nih.gov/pubmed/36325531 http://dx.doi.org/10.3389/fpsyt.2022.972141

Ejemplares similares

Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis
por: Hart, Xenia M., et al.
Publicado: (2022)

Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study
por: Hart, Xenia M., et al.
Publicado: (2023)

Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
por: Hart, Xenia M., et al.
Publicado: (2021)

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder
por: Hart, X. M., et al.
Publicado: (2022)

Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence
por: Cellini, Lorenzo, et al.
Publicado: (2021)

Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
por: Vierke, Christopher, et al.
Publicado: (2020)

An interesting case of serotonin syndrome precipitated by escitalopram
por: Sanyal, Debasish, et al.
Publicado: (2010)

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors
por: Funk, Cleo S. M., et al.
Publicado: (2022)

PS212. Effects of Proton Pump Inhibitors (PPI) on the Serum Concentrations of Venlafaxine
por: Paulzen, Michael, et al.
Publicado: (2016)

Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy
por: Hjorth, Olof, et al.
Publicado: (2022)

Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study
por: Margoob, Mushtaq A., et al.
Publicado: (2008)

Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Escitalopram Pharmacokinetics: A Cohort Study
por: Schoretsanitis, Georgios, et al.
Publicado: (2023)

Serotonin Surge: Intravenous Escitalopram as a Rare Cause of Drug-Induced Aplastic Anaemia
por: Hussain, Murtaza, et al.
Publicado: (2022)

Linezolid-Induced Near-Fatal Serotonin Syndrome During Escitalopram Therapy: Case Report and Review of Literature
por: Kulkarni, Ranganath R., et al.
Publicado: (2013)

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
por: Gjestad, Caroline, et al.
Publicado: (2015)

Kappa Opioid Receptors Reduce Serotonin Uptake and Escitalopram Efficacy in the Mouse Substantia Nigra Pars Reticulata
por: West, Alyssa M., et al.
Publicado: (2023)

Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT(3) receptor currents in NCB-20 cells
por: Park, Yong Soo, et al.
Publicado: (2019)

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
por: Wolff, Jan, et al.
Publicado: (2021)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone‐Induced Central Nervous System Demyelination
por: Tomas‐Roig, Jordi, et al.
Publicado: (2016)

Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report
por: Thumtecho, Suthimon, et al.
Publicado: (2021)

Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
por: Okada, Motohiro, et al.
Publicado: (2021)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants
por: Baumann, Pierre, et al.
Publicado: (2005)

Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report
por: Sato, Yasushi, et al.
Publicado: (2015)

Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer’s-like disease in mice
por: von Linstow, Christian Ulrich, et al.
Publicado: (2017)

Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K(+) channels in coronary arterial smooth muscle cells
por: Kim, Han Sol, et al.
Publicado: (2017)

In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry
por: Saylor, Rachel A., et al.
Publicado: (2019)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

Psychosocial stress and cannabinoid drugs affect acetylation of α-tubulin (K40) and gene expression in the prefrontal cortex of adult mice
por: Tomas-Roig, Jordi, et al.
Publicado: (2022)

PT705. Therapeutic Drug Monitoring (TDM) in maternal serum, amniotic fluid and umbilical cord blood during pregnancy and delivery
por: Paulzen, Michael, et al.
Publicado: (2016)

Corrigendum: In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry
por: Saylor, Rachel A., et al.
Publicado: (2019)

Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: A population‐based cohort study in older adults
por: Aakjær, Mia, et al.
Publicado: (2022)

Attachment style, anxiety coping, and personality-styles in withdrawn alcohol addicted inpatients
por: Wedekind, Dirk, et al.
Publicado: (2013)

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders
por: Wolff, Jan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4opdfe0c1969t8u68d82d7jic0